Related Experiment Video

Updated: Aug 17, 2026

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

[Treating chronic occlusive arterial disease]

M Rottman1, J Koepchen, B Angelkort

  • 1Medizinische Klinik Nord-Angiologie/Diabetologie, Klinikum Dortmund gGmbH. marcusrottmann@t-online.de

MMW Fortschritte Der Medizin
|June 7, 2005
PubMed

Insights

Managing cardiovascular risk factors is key for treating chronic occlusive arterial disease. All symptomatic patients with peripheral arterial occlusive disease (POAD) should receive antiplatelet therapy to prevent progression and manage symptoms.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Surgery
  • Preventive Cardiology

Background:

  • Chronic occlusive arterial disease management focuses on secondary prevention.
  • Cardiovascular risk factor management is the cornerstone of treatment across all disease stages.

Purpose of the Study:

  • To outline the treatment strategy for peripheral arterial occlusive disease (POAD) based on disease stage.
  • To emphasize the role of antiplatelet therapy and risk factor modification.

Main Methods:

  • Review of current treatment guidelines for POAD.
  • Staging of POAD based on clinical presentation and progression.
  • Consideration of interventional and surgical options based on lesion morphology.

Main Results:

  • Stage I POAD: focus on preventing progression.
  • Stage II POAD: risk factor management, antiplatelet agents, and potential for walking programs or revascularization.
  • Advanced stages: revascularization decisions based on morphology and comorbidities; PGE1 for unreconstructable cases; amputation as a last resort.

Conclusions:

  • Comprehensive management of cardiovascular risk factors is essential for all POAD stages.
  • Antiplatelet therapy is indicated for symptomatic POAD patients without contraindications.
  • Treatment decisions, including revascularization or amputation, must be individualized based on disease severity, morphology, and patient factors.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...